by Kara Golmont

We can’t wait to see you at AAA 2024!

April 3, 2024

The landscape of hearing healthcare is changing and audiologists can shape the future of patient care. Audiologists play the vital role in helping individuals with hearing loss regain their connection to sound. Whether your expertise is in hearing aids or you provide cochlear implant services, we are in an ever-changing industry and we look forward to working together to make cochlear implants accessible to those who could benefit.

Visit us in the HearTECH Hub or at Booth #1316.

Be sure to mark your calendar for the exciting sessions below!

Cochlear-at-AAA-2024-Download

Views expressed are those of the individual. Consult your hearing health provider to determine if you are a candidate for Cochlear technology. Outcomes and results may vary.

Professional perspectives: A closer look at remote care solutions

August 4, 2020

During a recent live webinar, a panel of audiology professionals shared their experiences with Cochlear’s remote service solutions. The panel discussion is now available as a standalone [downloadable] audio file, accessible below.

Dr. Mila Duke, Dr. Regina Presley and Dr. Melissa Anderson discuss remote care implementation in the evolving telehealth landscape. During the Q&A, the panel applies their breadth of clinical care experience to optimize Cochlear’s Remote Care solutions for their patients.

These experts examine the need for audiologists to be recognized as telehealth providers, especially regarding troubleshooting and counseling. Further, they review the patient benefits, as well as the cost and time savings associated with Cochlear Link as clinics strive to meet the demands of increasing service requests that parallel efficiency challenges.

Additionally, Dr. Presley carefully considers the call for streamlined services and protocols following the COVID pandemic. In her experience, Remote Check (not live yet) can keep patients and professionals conveniently connected, quicken patient monitoring and supplement professional insight. She notes that even in a newer telehealth environment, less tech savvy patients shouldn’t be discounted from utilizing remote services.

Cochlear Link, Remote Check and Remote Programming create an environment for clinicians to pinpoint urgent patient needs and prioritize accordingly.

Listen now to hear more!

File may not be compatible with all browser types. File has been updated.

About Remote Check

Remote Check is designed to be a convenient, at-home testing tool that allows Cochlear recipients with a Cochlear™ Nucleus® 7 Sound Processor to complete a series of hearing tests from their compatible iOS device using the Nucleus Smart App.* Results are then sent remotely to the recipient’s clinic for review by their clinician. The clinician can review the results by logging into their myCochlear Clinic professional portal, where they can access a comprehensive overview of their patient’s hearing health. Remote Check is designed to provide a snapshot of a patient’s hearing health so a clinician can quickly determine whether a patient is progressing well, or whether further clinical intervention is required.**

Remote Check is intended for ages 6 and older. The Remote Check feature is only visible and accessible if the feature is enabled by a clinician. Clinicians should consider the suitability of the feature before enabling Remote Check.

For more information on services and telehealth solutions, watch our full Remote Care webinar.

The Cochlear Nucleus 7 Sound Processor is compatible with iPhone, iPad and iPod touch. Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone, iPad Pro, iPad Air, iPad mini, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. The Cochlear Nucleus Smart App is available on App Store and Google Play. For complete smartphone compatibility information, please visit www.cochlear.com/compatibility.

App Store is a service mark of Apple Inc., registered in the U.S. and other countries.

Android and Google Play are registered trademarks of Google Inc.The Android robot is reproduced or modified from work created and shared by Google and used according to terms described in the Creative Commons 3.0 Attribution License.

* To use Remote Check, a patient requires: latest version of the Nucleus Smart App (Remote Check is part of this App) running on a compatible Apple device (iPhone or iPod Touch); Nucleus 7 Sound Processors with implant models: CI24RE, CI512, CI513, CI522, CI532, CI612, CI622 and CI632; compatible firmware on the Nucleus 7 Sound Processor (4.1.3.3 or later). A clinician requires access to Cochlear’s secure web-based myCochlear.com Professional Portal to access and review patient results. The recommended browser for accessing the Professional Portal is Google Chrome. A clinician also requires Custom Sound 5.1 or later software to upgrade the patient’s firmware to enable access to Remote Check. For sound processor and app compatibility information, visit www.cochlear.com/compatibility.

** Remote Check does not replace clinical care and does not involve remote programming of the sound processor.

NEW AudiologyOnline courses: Cochlear Case Studies Pediatric Series

April 6, 2021

A new AudiologyOnline series is now open for registration, Cochlear Case Studies Pediatric Series. Cochlear Case Studies is designed to provide professionals with a deeper knowledge and insight about cochlear implants through the use of case studies.

Course Details

Course 1: Encouraging Consistent Device Use

Wednesday, April 21st, 2021 at 12 pm EDT

Presenter: Elizabeth Preston, AuD, CCC-A

In this session, Dr. Preston will share a case and provide tips for encouraging consistent device use. After this course, participants will be able to list special considerations for implantation in children under 12 months of age, describe how data logging information can be used by professionals to support full-time CI device use and explain the importance of full-time device use for pediatric cochlear implant recipients.

Register now!

Course 2: Candidacy

Thursday, May 6th, 2021 at 12 pm EDT

Presenter: Kristin Gravel, AuD, CCC-A, PASC

In this session, Dr. Gravel will share a case and provide information about candidacy for our youngest recipients. After this course, participants will be able to list candidacy criteria for cochlear implants in pediatrics, describe topics that may be helpful when counseling families who are considering cochlear implantation for their child and list cochlear implant accessories that may be helpful for families of young children.

Register now!

Course 3: Supporting Bimodal and Bilateral Device Use

Wednesday, May 19th, 2021 at 12 pm EDT

Presenter: Meghan Nemeth, AuD, CCC-A

In this session, Dr. Nemeth will share a case and provide information about supporting bimodal and bilateral device use in young children. After this course, learners will define bimodal listening as it relates to cochlear implants in young children, list considerations for bilateral implantation vs bimodal listening for young children and describe features of cochlear implants that may be of benefit to young children who are bimodal listeners.

Register now!

In the United States, the Cochlear Nucleus cochlear implant system is intended for use in children 9 to 24 months of age who have bilateral profound sensorineural deafness and demonstrate limited benefit from appropriate binaural hearing aids. Children 2 years of age or older may demonstrate severe to profound hearing loss bilaterally for both series of implants.

In Canada, the Cochlear Nucleus Profile Plus (CI600) Series Implant System is intended for use in children 9 to 24 months of age who have bilateral profound sensorineural deafness and demonstrate limited benefit from appropriate binaural hearing aids. The Cochlear Nucleus Profile (CI500) Series and the Cochlear Nucleus Freedom Series (CI24RE (CA) and (ST), and CI422) Implant System is intended for use in children 12 to 24 months of age who have bilateral profound sensorineural deafness and demonstrate limited benefit from appropriate binaural hearing aids. Children 2 years of age or older may demonstrate severe to profound hearing loss bilaterally for both series of implants.